» Articles » PMID: 30271381

Vitamin D, FOXO3a, and Sirtuin1 in Hashimoto's Thyroiditis and Differentiated Thyroid Cancer

Overview
Specialty Endocrinology
Date 2018 Oct 2
PMID 30271381
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Protective effects of vitamin D have been reported in autoimmune and malignant thyroid diseases, though little is known about the underlying mechanism. Sirtuin 1 histon deacethylase (SIRT1) links the vitamin D pathway with regulation of transcription factor FOXO3a, a key player in cell cycle regulation and apoptosis. Aim of the present study was to investigate common single nucleotide polymorphisms (SNP's) in gene in respect to thyroid diseases, as well as to evaluate the hypothesis of Sirtuin1-FOXO3a interaction being a mediator of anti-proliferative vitamin D effects. The SNP's rs4946936/rs4945816/rs9400239 were genotyped in 257 patients with differentiated thyroid carcinoma (DTC), 139 patients with Hashimoto thyroiditis (HT) and 463 healthy controls (HC). Moreover, T-helper cells of HC and papillary thyroid cancer cell line BCPAP were incubated with 1,25(OH)D and/or SIRT1 inhibitor Ex-527 in order to elucidate SIRT1- dependent vitamin D effects on cell proliferation and gene expression . Patients with DTC tended to carry more often allele C in rs4946936 in comparison to HC (p = p = 0.08). rs9400239T and rs4945816C was more frequent in HT in comparison to HC (p = 0.02 and p = 0.01, respectively). In both DTC and HT, we could not find a correlation of SNP's with vitamin D status. However, on level, 1,25(OH)D showed an anti-proliferative effect in both T-helper cells and BCPAP, that was blocked by SIRT1 inhibition (T-helper cells: = 0.0059, BCPAP: = 0.04) and accompanied by elevated gene expression in T-helper cells ( = 0.05). rs9400239T and rs4945816C may constitute risk factors for HT, independent of the vitamin D status.This indicates the implication of FOXO3a in pathogenesis of autoimmune thyroid diseases. The dependency of anti-proliferative vitamin D effects on SIRT1 activity further suggests a key role of vitamin D-SIRT1-FOXO3a axis for protective vitamin D effects.

Citing Articles

Association between vitamin D status and thyroid cancer: a meta-analysis.

Hu Y, Xue C, Ren S, Dong L, Gao J, Li X Front Nutr. 2024; 11:1423305.

PMID: 38962442 PMC: 11221265. DOI: 10.3389/fnut.2024.1423305.


Therapeutic Potential of CRISPR/Cas in Hashimoto's Thyroiditis: A Comprehensive Review.

Upreti A, Mukherjee S Curr Gene Ther. 2024; 24(3):179-192.

PMID: 38310457 DOI: 10.2174/0115665232266508231210154930.


Impact of Vitamin D on Immunopathology of Hashimoto's Thyroiditis: From Theory to Practice.

Lebiedzinski F, Lisowska K Nutrients. 2023; 15(14).

PMID: 37513592 PMC: 10385100. DOI: 10.3390/nu15143174.


Relationships between serum levels of vitamins and papillary thyroid cancer: a single center case-control study.

Zhang D, Sun H, Kim H, Pino A, Frattini F, Wu C Gland Surg. 2023; 12(6):805-815.

PMID: 37441020 PMC: 10333764. DOI: 10.21037/gs-22-520.


On the Centennial of Vitamin D-Vitamin D, Inflammation, and Autoimmune Thyroiditis: A Web of Links and Implications.

Duntas L, Alexandraki K Nutrients. 2022; 14(23).

PMID: 36501065 PMC: 9736919. DOI: 10.3390/nu14235032.


References
1.
Sahin M, Ucan B, Ginis Z, Topaloglu O, Gungunes A, Colak Bozkurt N . Vitamin D3 levels and insulin resistance in papillary thyroid cancer patients. Med Oncol. 2013; 30(2):589. DOI: 10.1007/s12032-013-0589-5. View

2.
Ferrari S, Fallahi P, Antonelli A, Benvenga S . Environmental Issues in Thyroid Diseases. Front Endocrinol (Lausanne). 2017; 8:50. PMC: 5357628. DOI: 10.3389/fendo.2017.00050. View

3.
Yang H, Bi Y, Xue L, Wang J, Lu Y, Zhang Z . Multifaceted Modulation of SIRT1 in Cancer and Inflammation. Crit Rev Oncog. 2015; 20(1-2):49-64. DOI: 10.1615/critrevoncog.2014012374. View

4.
Palacios C, Gonzalez L . Is vitamin D deficiency a major global public health problem?. J Steroid Biochem Mol Biol. 2013; 144 Pt A:138-45. PMC: 4018438. DOI: 10.1016/j.jsbmb.2013.11.003. View

5.
Karger S, Weidinger C, Krause K, Sheu S, Aigner T, Gimm O . FOXO3a: a novel player in thyroid carcinogenesis?. Endocr Relat Cancer. 2008; 16(1):189-99. DOI: 10.1677/ERC-07-0283. View